PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Neuropathology, University of Zurich, Zurich, Switzerland.\', \'Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.\', \'Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.\', \'GA Generic Assays GmbH, Dahlewitz, Germany.\', \'Institute of Biotechnology, Faculty Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany.\', \'Faculty of Health Sciences Brandenburg, University of Technology Cottbus-Senftenberg, Senftenberg, Germany.\', \'Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.\', \'Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.\', \'Institute of Neuropathology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1010118
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34860860
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all